The momentum behind price transparency, and the Patient Deserves Price Tags Act in particular, suggests action on GFEs is on the horizon. This is the moment to refresh your knowledge and consider how you will position GFEs, because they are going to look very different from how they work today.
“Good enough” is no longer good enough. This article’s purpose is to take you beyond compliance: to show how a file most patients will never open has quietly become one of the most consequential pieces of financial data your hospital produces, and to give you practical guidance you can act on now.
Price Transparency is again making headlines after a new Executive Order reinforced existing regulations, signaling a renewed focus on ensuring healthcare providers and payers disclose actual prices rather than estimates.
In today’s era of intense public scrutiny on medical costs, what’s your pricing strategy? Does it pass the test of fairness and accuracy, without sacrificing revenue objectives? In this article, Panacea’s experts share their recommendations on where to start.
CMS penalties have dramatically increased since the Price Transparency Rule was released, and providers must take heed before CMS and a legislative gauntlet arrive at their front door.
The comprehensive diagnostic review includes analysis of CMS Price Transparency shoppable items and services to alert providers of risks and opportunities. Read more
Designed for hospitals just starting on their consumer display and machine-readable file, this session will include an overview of the requirements, 10 things you need to know, data requirements, how to layout the machine-readable file, and 3 options to consider for meeting the consumer display requirement.
This session will cover:
Watch our complimentary webinar to hear Panacea executives, Greg Adams, Fred Stodolak and Henry Guitterez discuss the process of pulling the critical data and technology together to comply with the CMS Price Transparency requirements that go into effect January 1, 2021.
Watch the Q&A session from the workshop
Frederick Stodolak, Chief Executive Officer at Panacea, joined the ICD10 Monitor Monday Special Report to discuss CMS Price Transparency and what providers need to know.
Raising sufficient general awareness of the new federal hospital price transparency rules set to take effect in just a little more than three months isn’t so much an issue anymore – industry leaders have been sounding alarm bells for much of the year, and even members of the public at large became well aware of the matter after the initial announcement generated plenty of national headlines in November 2019.
Read more
Federal health officials’ November 2019 announcement of sweeping changes to the rules governing hospital pricing transparency came with an admission that didn’t mince words – Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma called the applicable former rules “clear as mud” to patients, while U.S. Department of Health and Human Services (HHS) Secretary Alex Azar admitted that “right now, our system probably deserves an ‘F.’”
Read more
